News
-
Work continues to deliver support grants to West Oxfordshire businesses
West Oxfordshire District Council is making significant progress in delivering business support grants to coronavirus affected West Oxfordshire businesses.
-
Circassia Pharmaceuticals to transfer respiratory medicine rights AstraZeneca
Circassia Pharmaceuticals has announced it intends to terminate its U.S. commercial rights to Tudorza® and Duaklir® and transfer the assets to AstraZeneca.
-
Oxfordshire GPs and pharmacies to stay open on Easter Bank Holidays
Oxfordshire GP practices are going to be open for telephone appointments on Good Friday and Easter Monday. Pharmacies will also be open but may have different opening hours.
-
Oxford Biomedica joins COVID-19 vaccine development consortium
Oxford Biomedica has joined a consortium led by the Jenner Institute, Oxford University, to rapidly develop, scale-up and manufacture a potential vaccine candidate for COVID-19
-
Oxford-based biopharmaceutical firm working on COVID-19 treatment
Oxford-based biopharmaceutical company – Izana Bioscience – is working on antibody therapy treatment for patients with rapidly worsening COVID-19 symptoms.
-
Anneliese Dodds Oxford East MP appointed Shadow Chancellor
Anneliese Dodds, Oxford East MP, has been appointed shadow chancellor in today’s reshuffle of the shadow cabinet under new Labour leader Sir Keir Starmer.
-
Day services help homeless and vulnerably housed people in Oxford
Day services in Oxford are providing food and essential items to homeless and vulnerably housed people every day – despite the coronavirus lockdown.
-
Brookfield Asset Management acquires 50% stake in Harwell Campus JV
Brookfield Asset Management has acquired the private sector half shareholding in the Harwell Campus joint venture which manages and develops the campus.
-
Oxford City Council facilitates coronavirus grants to local small businesses
Oxford City Council has facilitated the first £170,000 of Government grants to local small businesses, to support them through the coronavirus outbreak.
-
Oxford Nanopore sequencing technology supports COVID-19 pandemic efforts
Oxford Nanopore is working with public health laboratories around the world, and researchers in related areas, to support the current COVID-19 pandemic.
-
Oxford firms collaborate to scale up COVID-19 antigen production
Two Oxford businesses – OXGENE™ and The Native Antigen Company – have formed a strategic partnership to scale-up SARS-CoV-2 (COVID-19) antigen production.
-
Oxford company to screen 15,000 drugs for COVID-19 treatment
The Oxford-based company Exscientia will use AI to screen 15,000 clinical molecules against key COVID-19 drug targets to progress rapid treatments.
-
First new ventilator to roll off production line in Abingdon this weekend
[siteorigin_widget class=”SiteOrigin_Widget_Image_Widget”][/siteorigin_widget] The first devices from the Government’s ventilator challenge will roll off a production line in Abingdon this weekend, ahead of delivery to the NHS next week, Chancellor of the Duchy of Lancaster Michael Gove has announced today. The news comes as some of the biggest names in British manufacturing race to step up…
-
OxVent ventilator project to proceed to the next stage of testing
OxVent ventilator project by team of engineers and medics at the University of Oxford and King’s College London to proceed to the next stage of testing.
-
Oxford City Council suspends garden waste collection service
Oxford City Council has temporarily suspended the garden waste collection service during the coronavirus crisis to help keep essential services running.
-
Oxford businesses able to apply for Government grants and rate relief
Oxford businesses are now able to apply for the Government’s new grants and rate relief to support them during the coronavirus outbreak.